Snrp116 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Snrp116, a critical component of the small nuclear ribonucleoprotein (snRNP) complex involved in the splicing of pre-mRNA. Snrp116 is part of the U4/U6.U5 tri-snRNP, one of the key components of the spliceosome, the complex machinery responsible for removing introns from pre-mRNA and joining exons together to form mature mRNA. The precise role of Snrp116 within the spliceosome involves the stabilization of the complex and facilitating the catalytic steps necessary for accurate splicing. By ensuring that the spliceosome is correctly assembled and functions efficiently, Snrp116 helps maintain the fidelity of gene expression, ensuring that only the correct sequences are included in the final mRNA transcript. Inhibiting Snrp116 disrupts this crucial process, providing researchers with a tool to study the specific contributions of Snrp116 to mRNA splicing and its broader implications for gene expression and cellular function.
In research settings, Snrp116 inhibitors are invaluable for exploring the molecular mechanisms of pre-mRNA splicing and the broader effects of splicing inhibition on cellular processes. By blocking Snrp116 activity, scientists can investigate how inhibition impacts the assembly and function of the spliceosome, particularly focusing on how the loss of Snrp116 affects the accuracy and efficiency of intron removal and exon joining. This inhibition allows researchers to study the downstream consequences on gene expression, such as the production of aberrant mRNA transcripts, altered protein synthesis, and potential disruptions in cellular function. Additionally, Snrp116 inhibitors provide insights into the interactions between Snrp116 and other spliceosomal components, shedding light on the complex regulatory networks that control splicing and maintain the integrity of the transcriptome. Through these studies, the use of Snrp116 inhibitors enhances our understanding of the critical role of splicing in gene regulation, the mechanisms that ensure accurate mRNA processing, and the broader implications of splicing regulation for cellular homeostasis and development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, could impact the epigenetic regulation of Snrp116 expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits transcription elongation, possibly affecting Snrp116 expression and its role in splicing. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, potentially downregulating Snrp116 expression. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B inhibits nuclear export, possibly impacting the cellular localization and function of Snrp116. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide can inhibit transcription factors and may influence Snrp116 expression indirectly. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Flavopiridol inhibits cyclin-dependent kinases, possibly affecting cell cycle-related expression of Snrp116. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin may disrupt DNA replication, potentially affecting Snrp116 expression. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin causes premature chain termination during translation, which might indirectly affect Snrp116 expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate may affect cellular metabolism, indirectly influencing Snrp116 expression and function. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, potentially impacting DNA replication and Snrp116 expression. | ||||||